Different studies have proved that the resistance/susceptibility to mastitis is genetically determined. The major histocompatibility complex in cows is known as bovine lymphocyte antigen (BoLA). Genes from the BoLA have been associated with the occurrence of infectious diseases such as mastitis and leukosis, especially the BoLA-DRB gene. The object of the present study was to detect associations between BoLA-DRB3 alleles and somatic cell count (SCC), as an indicator of resistance/susceptibility to mastitis in Holstein cattle (N = 123) from La Pampa, Argentina. Fisher's exact test and Woolf-Haldane odds ratio were applied to study the association between SCC and BoLA-DRB3 allele frequencies. Significant association was noted between BoLA-DRB3.2*23 and *27 alleles (p < 0.05) and protective or susceptibility effects, respectively. In addition, alleles BoLA-DRB3.2*20 and *25 exhibit suggestive association with high SCC (p < 0.1). These results were partially in agreement with data reported from Japanese Holstein cattle, but differed from those published by other authors. A possible explanation for the contrasting results could be that the mastitis is a multifactor disease caused by different pathogens. Moreover, most of the studies were carried out using PCR-RFLP method, which has less resolution than PCR-SBT because PCR-RFLP defined alleles included more than one sequenced alleles.
Polymorphisms of the BoLA-DRB3 gene are located primarily in the second exon [antigen binding site (ABS)] and, to a lesser extent, in the upstream regulatory region (URR). It can be hypothesised that exon 2 and the URR are under different types of natural selection. The aim of this work was to determine the URR-exon 2 haplotypes; 34 Holstein samples were genotyped by direct sequencing. A total of 7 URR alleles and 23 exon 2 alleles were detected, and 3 of the URR alleles were novel. Our results may suggest that no relationship exists between the URR and exon 2 of the BoLA-DRB3 gene (linkage disequilibrium P value > 0.05), most likely due to recombination over time. Our results also suggest that both regions of class II genes may be included in the development of new genotyping methods based on next-generation DNA sequencing technologies.
Polimorfismos del exón 2 del gen BoLA-DRB3 asociados con resistencia / susceptibilidad a leucosis en ganado Holstein de La Pampa
ResumenLa leucosis bovina enzoótica es una enfermedad del ganado bovino adulto causada por el retrovirus de la leucemia bovina. Se puede manifestar como: una forma asintomática aleucémica, con un número normal de linfocitos B en sangre; una forma de linfocitosis permanente, con aumento del número de linfocitos B y como una presentación linfoproliferativa tumoral en forma de linfosarcoma. Los alelos de los genes del Complejo Principal de Histocompatibilidad Bovino (BoLA) han sido asociados con resistencia y susceptibilidad a enfermedades infecciosas. El objetivo general del presente estudio consistió en asociar los polimorfismos del exón 2 del gen BoLA-DRB3.2, definidos mediante la técnica de Reacción en Cadena de la Polimerasa y la técnica de Polimorfismos de la Longitud de los Fragmentos de Restricción (PCR-RFLP), con resistencia/susceptibilidad a leucosis en vacas Holstein de La Pampa. Se basó en un diseño caso/control, para lo cual se tomó muestra de sangre a 150 animales en 3 oportunidades con intervalos de tres meses cada una. Los animales fueron incluidos en el grupo caso cuando dieron positivos en la prueba de inmunodeficiencia en agar (DIDA) y cuyo recuento linfocitario en sangre fue ≥ 10.000 linfocitos/µl y el grupo control estuvo constituido con animales negativos en DIDA y que tenían < 10.000 linfocitos/µl de sangre. Los tests Exacto de Fisher y Odds Ratio (OR) de Woolf-Haldane se utilizaron para estudiar la asociación entre recuento de linfocitos y resultados del DIDA con las variantes alélicas. En 82 animales genotipados por PCR-RFLP el alelo DRB3.2*22 evidenció un OR= 5,332 (p= 0,0138) y el alelo DRB3.2*11 mostró un OR= 0,11 (p=0,001) siendo más
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.